CARME (Catalan Remote Management Evaluation) study’s preliminar results, conducted by Philips Healthcare and the Catalonian Health Service (ICS) show significant benefits in the management of certain chronic diseases, thanks to telemedicine, an innovative technique that allows the continuous monitoring and a higher patient’s implication in the disease treatment. These results are presented during the [...]

Daiichi Sankyo Company, Limited , announced today that it has initiated a new large-scale pivotal Phase 3 trial for edoxaban, its investigational oral Factor Xa inhibitor. This new study, called HOKUSAI (pronounced hoe-koo-sigh) VTE, is evaluating the safety and efficacy of edoxaban in reducing recurrent venous thromboembolic (VTE) complications in patients with deep-vein thrombosis (DVT) [...]